Society for Translational Oncology


Highlights from STO's educational activities, including content associated with the Society and its journal The Oncologist. RSS Feed URL

Society for Translational Oncology navigateright Episode

Innovations in Cell Therapy

Autologous T cells that have been genetically redirected with chimeric antigen receptors (CARs) specific to the CD19 antigen have achieved remarkable success in inducing rapid and sometimes complete eradication of B cell leukemias and lymphomas. New forms of CARs, including those targeting new surface molecules alone and in combination with additional functionalities, are under intense investigation. We will discuss some of our innovations in cell therapies, including strategies designed to overcome tumor heterogeneity and the tumor microenvironment.

Video Overview:

Marcela Maus, MD, PhD

MGH Cancer Center

STO gratefully acknowledges educational grants in partial support of this activity from:
Agios Pharmaceuticals
Celgene Corporation
Novartis Pharmaceuticals Corp.
Pfizer Inc.